<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:RETA (USA) Also Trade In: Germany

Reata Pharmaceuticals Inc $ 166.76 8.84 (5.6%)

Volume:
2,000,123
Avg Vol (1m):
322,840
Market Cap $:
5.00 Bil
Enterprise Value $:
4.80 Bil
P/E (TTM):
0.00
P/B:
0.00
Warning! GuruFocus has detected 1 Severe warning sign with RETA. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

3/10
Current Vs Industry Vs History
Cash-To-Debt 3.51
Equity-to-Asset -0.11
Debt-to-Equity -2.39
Debt-to-EBITDA -0.73
N/A
Piotroski F-Score 4
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.69
DISTRESS
GREY
SAFE
Beneish M-Score -3.19
Not Manipulator
Manipulator
WACC vs ROIC
ROIC 0%
WACC 18.34%

Profitability

2/10
Current Vs Industry Vs History
Operating Margin % -399.23
Net Margin % -410.37
ROA % -39.1
ROC (Joel Greenblatt) % -6447.18
3-Year Revenue Growth Rate -40.4
3-Year EPS without NRI Growth Rate -122.6
N/A

Ratios

Current Vs Industry Vs History
PS Ratio 168.58
EV-to-EBIT -43.48
N/A
EV-to-EBITDA -43.68
N/A
EV-to-Revenue 164.1
N/A
Current Ratio 4.24
Quick Ratio 4.24

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -71.4

Valuation & Return

Current Vs Industry Vs History
Price-to-Median-PS-Value 12.36
Earnings Yield (Greenblatt) % -2.3